ArticleGlobal challenges (Hoboken, NJ)2025
A Soil Monitoring Law for Europe.
Article in Global challenges (Hoboken, NJ), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Hydrogel-Enabled Delivery Systems for Agricultural Resilience: Controlled Release, Soil Interactions and Performance Constraints: A Review.Gels (Basel, Switzerland) · 2026Review
- The contribution of soil extract composition and cyclic moisture dynamics to the physicochemical aging of superabsorbent polyacrylic acid and polyacrylamide hydrogels.Scientific reports · 2026Article
- Europe's land take and the loss of nature and cropland to artificial surfaces.Nature communications · 2026Article
- Iron Nanoparticles Derived from Olive Mill Wastewater for Sustainable Soil Remediation.Nanomaterials (Basel, Switzerland) · 2026Article
- Article
- A Soil Monitoring Law for Europe.Global challenges (Hoboken, NJ) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over 60% of European soils are unhealthy according to the Soil Mission board estimates and the indicators presented in the European Union (EU) Soil degradation dashboard. The situation may worsen if no policy interventions are taken. The unsustainable use of natural resources, in particular the degradation of soils, precipitates biodiversity loss, exacerbated by the climate crisis. In particular, in the EU alone, soil degradation costs over €50 billion per year due to the loss of essential services they provide and to the impact on human health. Here a more precise estimation of the soil degradation cost related to a set of soil degradation processes, ranging between €40.9 and 72.7 billion per year is presented. This newly updated estimate compared to the Impact assessment of the Soil Monitoring Law takes into account the costs of soil erosion, contamination, phosphorus losses, soil carbon losses, nitrogen losses, soil compaction, and soil sealing. However, this estimation might double if it is added to the costs of soil biodiversity loss, floods, droughts, off-site effects of soil erosion, and health consequences of soil contamination. Therefore, further research is needed to address this knowledge gap and estimate the missing costs. Soil degradation is a critical issue with transboundary implications that requires urgent attention and action at the EU level. The costs of soil degradation are substantial, both in terms of environmental impacts and economic consequences, highlighting the importance of investing in sustainable soil management practices and a harmonized EU soil monitoring system. By addressing soil degradation through the proposed Soil Monitoring Law, investing significant amounts for research and innovation in the Soil Mission, and promoting international cooperation, the EU can take solid steps toward protecting its soil resources and achieving a sustainable future for all.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.